Guangzhou (1)

128 Patients Were Randomly Assigned 1:1 (1)

Changes in HbA1C From Baseline at 18 Weeks of Treatment (1)

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients (1)

InvestigatorInitiate Trial (1)

Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect (1)

Metformin and Insulin Glargine Combined With Chiglitazar Sodium Tablets 48mg/ Day Group (1)

Metformin and Insulin Glargine Combined With Placebo Group (1)

Not yet recruiting (1)

n/a (1)

Yanbing Li (1)

chiglitazar placebo (1)

chiglitazar sodium (1)

drug (1)

Other (1)

Interventional (1)

changes in hba1c from baseline at 18 weeks of treatment

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Guangzhou, Guangdong, China

the First Affiliated Hospital of Sun Yat-sen University

Aug 17, 2023